Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Dr.-Kyle-Holen"

1 News Found

Moderna and Merck announce an investigational individualized neoantigen therapy
Diagnostic Center | April 17, 2023

Moderna and Merck announce an investigational individualized neoantigen therapy

mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients